|
AU2006200015A1
|
|
Preparation of a lipid blend and a phospholipid suspension containing a lipid blend, and contrast agents based on these
|
|
IL153555D0
|
|
Ternary radiopharmaceutical complexes, kits comprising them and their use in radioimaging
|
|
AU2323602A
|
|
Azolo triazines and pyrimidines
|
|
AU7371301A
|
|
4,4-disubstituted-3,4-dihydro-2-)1H)- quinazolinones useful as HIV reverse transcriptase inhibitors
|
|
AU8064101A
|
|
Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors
|
|
WO0210124A2
|
|
Salt forms of an hiv protease inhibitor
|
|
AU8063601A
|
|
Crystalline and salt forms of an hiv protease inhibitor
|
|
AU8063201A
|
|
CRF<sub>2</sub> ligands in combination therapy
|
|
AU7585701A
|
|
Thrombin or factor xa inhibitors
|
|
AU6871101A
|
|
Heteroaryl-phenyl substituted factor xa inhibitors
|
|
WO0200655A1
|
|
1 - (heteroaryl-phenyl) - condensed pyrazol derivatives as factor xa inhibitors
|
|
EP1296678A2
|
|
Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
|
|
AU7143501A
|
|
Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
|
|
AU6871001A
|
|
Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy
|
|
AU6830301A
|
|
Hepatitis c protease exosite for inhibitor design
|
|
AU4811301A
|
|
Radiopharmaceuticals for imaging infection and inflamation
|
|
AU6172801A
|
|
Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging
|
|
ZA200103756B
|
|
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity.
|
|
WO0183486A1
|
|
Tricyclic fused pyridine and pyrimidine derivatives as crf receptor antagonists
|
|
AU5310801A
|
|
Cyclic lactams as inhibitors of a-beta protein production
|
